Conventional diabetes treatments such as lifestyle modification, insulin or secretagogues, and insulin sensitizers are insufficient for achieving adequate glycemic control in most RMS patients, and their extreme insulin resistance limits the efficacy of high-dose insulin [31, 32]. This evidence concerns the gene INS and Insulin resistance.